⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRIS News
Curis Inc
Form 8-K
sec.gov
CRIS
Curis Doses First Five Patients in TakeAim CLL Study
prnewswire.com
CRIS
Amylin Analogs and Combination Therapies Clinical Trial Landscape Expands as 15+ Leading Companies Accelerate Drug Development | DelveInsight
globenewswire.com
AZN
LLY
NVO
PFE
AMGN
BMY
JNJ
REGN
VKTX
ZETA
CRSP
IONS
AXSM
MRK
GSK
SNY
IMUX
BMEA
ALKS
ALT
AARD
NOV
CARM
CRIS
LPCN
GILD
REG
SPRO
ABSI
ALZN
ANVS
BV
ARCL
ACIU
RARE Drug Development Symposium Marks 10th Anniversary with Dedicated Pitch Sessions and The Theme and Call to Action to Align Advocates, Science and Industry
prnewswire.com
BIIB
REGN
GILD
BTE
BROS
BFLY
BCTX
BCRX
BTAI
ALRS
CAPR
CRIS
CYCN
EXAS
FATE
GNTX
HRMY
INCY
IONS
KODK
LAKE
LULU
MRNA
NBIX
NTRA
OCGN
ORGN
PGEN
PLRX
RARE
RGNX
RXRX
SAVA
SGMO
SNOW
SRPT
STEM
TGTX
TLSA
TXG
VRTX
ZETA
Cristcot Presents Poster and Select Oral Presentation for Implementing Endocrine Principles to Assess Safety and Compliance within a Clinical Trial at ENDO 2026
globenewswire.com
CRIS
Curis Announces Positive Emavusertib Update
prnewswire.com
CRIS
Curis Consents First Six Patients in TakeAim CLL Study
prnewswire.com
CRIS
Form 8-K
sec.gov
CRIS
Form 8-K/A
sec.gov
CRIS
Form 8-K
sec.gov
CRIS